Top Banner
Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber [email protected]
33

Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber [email protected].

Jan 18, 2016

Download

Documents

Kerry Lane
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

Cell Cycle IIMolecular Biology of Cancer

MCB 5068 November 10, 2015Jason Weber

[email protected]

Page 2: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

Molecular Biology of Cancer

Page 3: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

CANCER TAKES TIME

Page 4: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

CANCER IS A DISEASE OF GENETIC MUTATIONS

ACCUMULATION OF MANY MUTATIONS CAUSES CANCER

Page 5: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

YOU MUST REMEMBER THAT ALL MUTATIONS ARE

RANDOMYOU WILL MUTATE DRIVERS AND PASSENGERS

Page 6: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

WHAT MAKES A CANCER CELL A CANCER CELL?

UNLIMITED GROWTHUNLIMITED MOVEMENT

Page 7: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.
Page 8: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

Growth Factorsint-2sis

Growth Factor ReceptorserbB-1fmskitmeterbB-2

Cytoplasmic Kinasessrcbcr-ablfeslckyes

Nuclear Proteinsetsfosjunmyc

FGFPDGF

EGF-RCSF-1RStem Cell GF-RHepatic GF-RHeregulin R

FAMOUS ONCOGENES

Page 9: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.
Page 10: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

The Cell Cycle

Page 11: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.
Page 12: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

FAMILIAL CANCER SYNDROMES

Li-Fraumenip53

Deleted in PancreasSmad4

RetinoblastomaRb

Breast CancerBrca1,2

Wilms TumorWT1

Nonpolyposis ColonMSH2,MLH1

Neurofibromatosis 1,2NF1,NF2

von Hippel-LindauVHL

Adenomatous PolyposisAPC

MelanomaINK4a/ARF

Cowden DiseasePTEN

GorlinPTCH

Multiple Endocrine NeoplasiaMEN1

Page 13: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

THE DEFINITION OF A TUMOR SUPPRESSOR

Classical Features:

1. Loss of function mutations2. Targeted allelic loss- Methylation or Deletion3. Inherited mutations that predispose to cancer4. Somatic mutation in spontaneous tumors5. Ability to inhibit transformed cells in vitro

Page 14: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.
Page 15: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.
Page 16: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

ACTIVATING THE p53 RESPONSE

Page 17: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

p53 Modifications

Page 18: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

ACCESSING THE CELL CYCLE MACHINERY

Page 19: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

The Ink4a/Arf Locus

Page 20: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.
Page 21: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.
Page 22: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

1b 1a 32CpG CpG

DE-REPRESSION

ONCOGENES

RAS

PRC1PRC2

ARF INK4A

Page 23: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

SELECTIVE PRESSURE THROUGH STRESS

From environment:

-Low oxygen-Low nutrients-Radiation-Ligands

From self:

-Random mutant-ROS-Grow too fast

Dealing with it:

-Arrest/Senesce-Apoptosis

MUTATE

Page 24: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

Not just division… But growth

Page 25: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.
Page 26: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

Understanding what translation is really all about

Growth signals

PI-3k/mTOR PathwayAnd

Regulators ofRibosome biogenesis 60S 40S

5’

AA

AA

AA

AA

AA-3’

UTR

UTR

Active translationRibosome biogenesis

rRNA synthesisrRNA processingrRNA export

Page 27: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

PI3K

GFR

Akt

Rheb

Ras

mTOR

Tuberin/Hamartin

PTEN

Neurofibromin

Tuberous sclerosis complex

Neurofibromatosis type 1 (NF1)

Cowden Syndrome Lhermitte-Duclos

disease

S6KeIF4E

NPMARF p68

Page 28: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

THINKING ABOUT TRANSLATION

Page 29: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

THE NUCLEOLUS

NPMARF

Page 30: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

MAKING RIBOSOMAL RNA

Page 31: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.
Page 32: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

Micro RNA

Page 33: Cell Cycle II Molecular Biology of Cancer MCB 5068 November 10, 2015 Jason Weber jweber@DOM.wustl.edu.

PUTTING IT ALL TOGETHER

1. IDENTIFY THE MUTATIONS 2. SEPARATE DRIVERS FROM PASSENGERS

3. FIND DRUGGABLE TARGETS 4. TEST IT ON THE RIGHT PATIENTS